Leukemia-induced bone marrow depression: Effects of gangliosides on erythroid cell production

International Journal of Cancer

Volumn 82, Issue 1, 1999, Pages 92-97

  Sietsma, Hannie ^a,b   Kamps, Willem A ^b   Dontje, Bert ^a   Hendriks, Dick ^c   Kok, Jan W ^a   Vellenga, Edo ^c   Nijhof, Willem ^a,c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GANGLIOSIDE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ARTICLE; BONE MARROW DEPRESSION; BURST FORMING UNIT E; CANCER CELL; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; ERYTHROID CELL; ERYTHROPOIESIS; FEMALE; GROWTH INHIBITION; IMMUNE RESPONSE; LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD34; BONE MARROW; ERYTHROID PROGENITOR CELLS; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; GANGLIOSIDES; HUMANS; LEUKEMIA; MICE; MICE, INBRED C57BL;

EID: 0033516709     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990702)82:1<92::AID-IJC16>3.0.CO;2-J     Document Type: Article

References (23)

1. ALEXANDER, W.S., Cytokines in hematopoiesis. Int. Rev. Immunol.,16, 651-682 (1998).
2. ANH-TUAN, N., PICK, J., MOD, A. and HOLLAN, S.R., Gangliosides in acute myeloid leukemia (AML) and non-hodgkin's lymphoma (NHL). Europ. J. Clin. Oncol., 22, 1003-1007 (1986).
3. BERGELSON, L.D., Serum gangliosides as endogenous immunomodulators. Immunol. Today, 16, 483-486 (1995).
4. DE WOLF, J.T., MULLER, E.W., HENDRIKS, D.H., HALIE, R.M. and VELLENGA, E., Mast cell growth factor modulates CD36 antigen expression on erythroid progenitors from human bone marrow and peripheral blood associated with ongoing differentiation. Blood, 84, 59-64 (1994).
5. HOMANS, A.C., COHEN, J.L., BARKER, B.E. and MAZUR, E.M., Aplastic presentation of acute lymphoblastic leukemia: evidence for cellular inhibition of normal hematopoietic progenitors. Amer. J. Pediatr. Hematol./ Oncol., 11, 456-462 (1989).
6. KAUCIC, K., GROVAS, A., LI, R., QUINONES, R. and LADISCH, S., Modulation of human myelopoiesis by human gangliosides. Exp. Hematol., 22, 52-59(1994).
7. LADISCH, S., WU, Z.L., FEIG, S., ULSH, L., SCHWARTZ, E., FLOUTSIS, G., WILEY, F., LENARSKY, C. and SEEGER, R., Shedding of GD2 ganglioside by human neuroblastoma. Int. J. Cancer, 39, 73-77 (1987).
8. LADISCH, S., LI, R. and OLSON, E., Ceramide structure predicts tumor ganglioside immunosuppressive activity. Proc. nat. Acad. Sci. (Wash.), 91, 1974-1978 (1994).
9. LENZ, R. and PLUZNIK, D.H., Possible role of gangliosides in the interaction of colony-stimulating factor with granulocyte-macrophage progenitor cells. Exp. Hematol., 13, 539-544 (1985).
10. MATLAUB, Y.H., BRUNNING, R.D., ARTHUR, D.C. and RAMSAY, N.K.C., Severe aplastic anemia preceding acute lymphoblastic leukemia. Cancer, 71, 264-268 (1993).
11. MAYANI, H., LITTLE, M.T., DRAGOWSKA, W., THORNBURY, G. and LANSDORP, P.M., Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34(+) cells purified from cord blood and fetal liver. Exp. Hematol., 23, 422-42 (1995).
12. MEUILLET, E., CREMEL, G., DREYFUS, H. and HICKS, D., Differential modulation of basic fibroblast and epidermal growth factor receptor activation by ganglioside GM3 in cultured retinal Muller glia. Glia, 17, 206-216 (1996).
13. NAJMAN, A., KOBARII, L., KHOURY, E., BAILLOU, C., LEMOINE, F. and GUIGON, M., Suppression of normal hemalopoiesis during acute leukemias. In A. Najman (ed.). Negative regulators of hematopoiesis, p. 140, New York Academy of Sciences, New York (1991).
14. NIJHOF, W., DE HAAN, G., PIETENS, J. and DONTJE, B., Mechanistic options of erythropoietin-stimulated erythropoiesis. Exp. Hematol., 23, 369-375 (1995).
15. NOJIRI, H., TAKAKU, F., TERUI, Y., MIURA, Y., and SAITO, M. Ganglioside GM3: An acidic membrane component that increases during macrophage-like cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemic cell lines HL-60 and U937. Proc. nat. Acad. Sci. (Wash.), 83,782-786(1986).
16. OBOYLE, K.P., FREEMAN, K., KALISIAK, A., AGREGADO, A. and SCHEINBERG, D.A., Patterns of ganglioside expression in B cell neoplasms. Leukemia Lymphoma, 21, 255-266 (1996).
17. OLSHEFKI, R. and LADISCH, S., Intercellular transfer of shed tumor cell gangliosides. FEBS Lett., 386, 11-14 (1996).
18. PIZZO, P.A. and POPLACK, D.G., Principles and practice of pediatric oncology, Lippincott, Philadelphia (1997).
19. SAQR, H.E., PEARL, D.K. and YATES, A.J., A review and predictive models of ganglioside uptake by biological membranes. J. Neurochem., 61, 395-411 (1993).
20. SENN, H.J., ORTH, M., FITZKE, E., WIELAND, H. and GEROK, W., Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins. Eur. J. Biochem., 181, 657-662 (1989).
21. WANG, C.Q., UDUPA, K.B. and LIPSCHITZ, D.A., Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development. J. Cell Physiol., 162, 134-138 (1995).
22. YATES, A.J., SAQR, H.E. and VAN BROCKLYN, J., Ganglioside modulation of the PDGF receptor. A model for ganglioside functions. J. Neurooncol., 24, 65-73 (1995).
23. YOUSSOUFIAN, H., LONGMORE, G., NEUMANN, D., YOSHIMURA, A. and LODISH, H.F., Structure, function, and activation of the erythropoietin receptor. Blood, 81, 2223-2236 (1993).